Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950123-00-006807
Filing Date
2000-07-26
Accepted
2000-07-26 00:00:00
Documents
5
Effectiveness Date
2000-07-26

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. s-8.txt S-8 24650
2 NON-QUALIFIED STOCK OPTION PLAN ex4-1.txt EX-4.1 22223
3 1999 INCENTIVE AND NON-QUALIFIED STOCK OPTION PLAN ex4-2.txt EX-4.2 33016
4 OPINION OF SAUL, EWING, REMICK & SAUL LLP ex5.txt EX-5 3258
5 CONSENT OF KPMG LLP ex23-1.txt EX-23.1 416
  Complete submission text file 0000950123-00-006807.txt   85781
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: S-8 | Act: 33 | File No.: 333-42274 | Film No.: 679373
SIC: 2835 In Vitro & In Vivo Diagnostic Substances